TY  - JOUR
T1  - REcommendations on use of prostate-specific antigen for prostate cancer screening
AU  - Garnick MB
Y1  - 2012/04/04
N1  - 10.1001/jama.2012.396
JO  - JAMA
SP  - 1372
EP  - 1374
VL  - 307
IS  - 13
N2  - 
To the Editor: Three Commentaries1- 3 provided differing interpretations of the conclusion from the draft report of the US Preventive Services Task Force (USPSTF) that the harms of prostate-specific antigen (PSA) screening outweigh the benefits of treatment for PSA screen-detected prostate cancer and of the recommendation against the routine use of the test. Scientific evidence is lacking for their arguments for continuing the widespread use of PSA testing.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.396
UR  - http://dx.doi.org/10.1001/jama.2012.396
ER  -